A Comparative Study of KES524 in Patients With Obesity Disease

NCT00165685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Sibutramine Hydrochloride Monohydrate

Sponsor

Eisai Limited